VEON Ltd. ORD SHS Financial Statements (VEON-RX) |
||||||||||
VEONsmart-lab.ru | % | 2022Q3 | 2022Q4 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
---|---|---|---|---|---|---|---|---|---|---|
Report date | 24.07.2023 | 24.07.2023 | 30.09.2023 | 31.12.2023 | 31.03.2024 | 31.03.2024 | ||||
Currency | USD | USD | USD | USD | USD | USD | ||||
Financial report URL | ||||||||||
Revenue, bln rub | ? | 940.0 | 945.0 | 953.0 | 942.0 | 2 840 | ||||
Operating Income, bln rub | 246.0 | 257.0 | 226.0 | 202.0 | 685.0 | |||||
EBITDA, bln rub | ? | 454.0 | 444.0 | 413.0 | 386.0 | 1 243 | ||||
Net profit, bln rub | ? | 296.0 | 448.0 | 72.0 | 57.0 | 577.0 | ||||
OCF, bln rub | ? | 537.0 | 646.0 | 0.000 | 0.000 | 646.0 | ||||
CAPEX, bln rub | ? | 974.0 | 199.0 | 0.000 | 0.000 | 199.0 | ||||
FCF, bln rub | ? | 1 511 | 447.0 | 0.000 | 0.000 | 447.0 | ||||
Dividend payout, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |||||
Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
Dividend payout ratio, % | 0.00% | 0.00% | 0.00% | 0.00% | 0 | |||||
OPEX, bln rub | 694.0 | 394.0 | 697.0 | 437.0 | 1 528 | |||||
Cost of production, bln rub | 821.0 | 294.0 | 0.000 | 303.0 | 597.0 | |||||
R&D, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |||||
Interest expenses, bln rub | 125.0 | 132.0 | 0.000 | 0.000 | 132.0 | |||||
Assets, bln rub | 15 851 | 15 096 | 12 584 | 8 218 | 7 268 | 7 268 | ||||
Net Assets, bln rub | ? | 489.0 | 776.0 | 1 066 | 1 076 | 903.0 | 903.0 | |||
Debt, bln rub | 12 105 | 7 571 | 4 846 | 4 761 | 4 169 | 4 169 | ||||
Cash, bln rub | 3 412 | 4 010 | 2 408 | 1 737 | 1 315 | 1 315 | ||||
Net debt, bln rub | 8 693 | 3 561 | 2 438 | 3 024 | 2 854 | 2 854 | ||||
Ordinary share price, rub | 9.25 | 12.3 | 19.5 | 19.7 | 24.0 | 33.2 | ||||
Number of ordinary shares, mln | 67.4 | 70.2 | 73.9 | 70.2 | 70.2 | |||||
Market cap, bln rub | 0 | 825 | 1 369 | 1 456 | 1 686 | 2 332 | ||||
EV, bln rub | ? | 8 693 | 4 386 | 3 807 | 4 480 | 4 540 | 5 186 | |||
Book value, bln rub | -2 635 | -1 184 | -542 | 727 | 550 | 550 | ||||
EPS, rub | ? | 4.39 | 6.38 | 0.97 | 0.81 | 8.21 | ||||
FCF/share, rub | 22.4 | 6.36 | 0.00 | 0.00 | 6.36 | |||||
BV/share, rub | -17.6 | -7.72 | 9.83 | 7.83 | 7.83 | |||||
EBITDA margin, % | ? | 48.3% | 47.0% | 43.3% | 41.0% | 43.8% | ||||
Net margin, % | ? | 31.5% | 47.4% | 7.56% | 6.05% | 20.3% | ||||
FCF yield, % | ? | 0.00% | 183.1% | 32.6% | 0.00% | 0.00% | 19.2% | |||
ROE, % | ? | 0.00% | 38.1% | 42.0% | 6.69% | 6.31% | 63.9% | |||
ROA, % | ? | 0.00% | 1.96% | 3.56% | 0.88% | 0.78% | 7.94% | |||
P/E | ? | 2.79 | 3.06 | 20.2 | 29.6 | 4.04 | ||||
P/FCF | 0.55 | 3.06 | 5.22 | |||||||
P/S | ? | 0.88 | 1.45 | 1.53 | 1.79 | 0.82 | ||||
P/BV | ? | 0.00 | -0.70 | -2.53 | 2.00 | 3.07 | 4.24 | |||
EV/EBITDA | ? | 9.66 | 8.58 | 10.8 | 11.8 | 4.17 | ||||
Debt/EBITDA | 7.84 | 5.49 | 7.32 | 7.39 | 2.30 | |||||
R&D/CAPEX, % | 0.00% | 0.00% | 0 | |||||||
CAPEX/Revenue, % | 103.6% | 21.1% | 0.00% | 0.00% | 7.01% | |||||
VEON Ltd. ORD SHS shareholders |